Home|Journals|Articles by Year|Audio Abstracts

Review Article

N-Heterocycle Derivatives: An Update on the Biological Activity in Correlation with Computational Predictions

Sahar Alghamdi, Rasha suliman, Rawan Alshehri, Razan Almahmoud, Renad Alhujirey.

Cited by 2 Articles

This study focuses on selected potent N-heterocycle scaffolds including Oxazolone, Oxazole, and Oxadiazole. Numerous studies have examined their biological activity against cancer, infectious diseases, and importantly inflammation. Thus, efforts have been done to computationally predict and investigate the drug-likeness properties for these reported N-heterocycle derivatives. In this study, 19 articles have been reviewed for an anticancer, antimicrobial, anti-inflammatory activity for N-heterocycle compounds. The most potent compounds were examined for their pharmacokinetic properties and the drug-likeness properties using the SwissADME web server. Moreover, a target prediction was performed using the Molinspiration webserver to predict possible biological targets. A total of 30 compounds were selected for their potent biological activity that was determined by IC50, MIC, and edema inhibition for cancer, infection, and inflammation, respectively. Our computational predictions showed that all compounds have the recommended molecular weight except for C5, C6, and I5. Furthermore, C2, C3, C8, M1, M2, M4, I1, and I4 compounds are expected to have BBB permeability suggesting a central nervous activity. Additionally, most of the compounds showed acceptable GI absorption. Target prediction studies suggested that compounds could modulate their biological responses via channel modulators, and receptors with different degrees. The selected N- heterocycle derivatives possess promising medicinal properties that could be utilized for future drug discovery.

Key words: Oxazolone, oxazole, oxadiazole, benzoxazole, pharmacokinetics, target prediction.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.